The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed 340B drug rebate models.

The 340B requirement has long been a bone of contention ... Last year, for example, a federal appeals court sided with Sanofi, AstraZeneca, and Novo Nordisk in a dispute claiming that recipients ...

J&J said its plan to give hospitals rebates instead of upfront discounts on 340B-eligible drugs is necessary to prevent waste and abuse, while hospitals — and the government — maintain the ...